Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis

American Heart Journal

Volumn 162, Issue 2, 2011, Pages 324-330

  Chang, Tara I ^a   Shilane, David ^a   Brunelli, Steven M ^b   Cheung, Alfred K ^c,d   Chertow, Glenn M ^a   Winkelmayer, Wolfgang C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORBIDITY; PEPTIDYL-DIPEPTIDASE A; PROPENSITY SCORE; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 80051668331     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.05.004     Document Type: Article

References (30)

1. CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N Engl J Med 316 1987 1429 1435
2. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators N Engl J Med 325 1991 293 302
3. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100 000 patients in randomized trials Circulation 97 1998 2202 2212
4. U.S. Renal Data System USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States 2010 National Institutes of Health NIDDK Bethesda, MD
5. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients Am J Kidney Dis 45 2005 S1 S153
6. G. Eknoyan, G.J. Beck, and A.K. Cheung Effect of dialysis dose and membrane flux in maintenance hemodialysis N Engl J Med 347 2002 2010 2019 (Pubitemid 35461657)
7. T. Greene, G.J. Beck, and J.J. Gassman Design and statistical issues of the hemodialysis (HEMO) study Control Clin Trials 21 2000 502 525
8. J.N. Cohn, and G. Tognoni A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675 (Pubitemid 33126822)
9. M.A. Pfeffer, K. Swedberg, and C.B. Granger Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766 (Pubitemid 37093915)
10. P.C. Austin, and M.M. Mamdani A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use Stat Med 25 2006 2084 2106 (Pubitemid 43950281)
11. P.C. Austin Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples Stat Med 28 2009 3083 3107
12. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
13. J. Kosanke, and E. Bergstralh GMATCH macro: Match 1 or more controls to cases using the greedy algorithm Mayo Clinic College of Medicine 2004 Available at: http://mayoresearch.mayo.edu/mayo/research/biostat/sasmacros.cfm. Last accessed October 1, 2010
14. T. Isakova, O.M. Gutierrez, and Y. Chang Phosphorus binders and survival on hemodialysis J Am Soc Nephrol 20 2009 388 396
15. T.F. Griffith, B.S. Chua, and A.S. Allen Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients Am J Kidney Dis 42 2003 1260 1269 (Pubitemid 37486771)
16. B. Kestenbaum, D.L. Gillen, and D.J. Sherrard Calcium channel blocker use and mortality among patients with end-stage renal disease Kidney Int 61 2002 2157 2164 (Pubitemid 34539333)
17. R.N. Foley, C.A. Herzog, and A.J. Collins Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study Kidney Int 62 2002 1784 1790 (Pubitemid 35286287)
18. A. Ishani, C.A. Herzog, and A.J. Collins Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? Kidney Int 65 2004 1017 1025 (Pubitemid 38251078)
19. K.C. Abbott, F.C. Trespalacios, and L.Y. Agodoa Beta-blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality Arch Intern Med 164 2004 2465 2471 (Pubitemid 39628074)
20. F.C. Trespalacios, A.J. Taylor, and L.Y. Agodoa Incident acute coronary syndromes in chronic dialysis patients in the United States Kidney International 62 2002 1799 1805 (Pubitemid 35286289)
21. W.C. Winkelmayer, D.M. Charytan, and R. Levin Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction Am J Kidney Dis 47 2006 301 308 (Pubitemid 43121333)
22. A.K. Berger, S. Duval, and H.M. Krumholz Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction J Am Coll Cardiol 42 2003 201 208 (Pubitemid 36851405)
23. F. Zannad, M. Kessler, and P. Lehert Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies Kidney Int 70 2006 1318 1324 (Pubitemid 44435184)
24. F.C. Trespalacios, A.J. Taylor, and L.Y. Agodoa Heart failure as a cause for hospitalization in chronic dialysis patients Am J Kidney Dis 41 2003 1267 1277 (Pubitemid 36637983)
25. G. Cannella, E. Paoletti, and R. Delfino Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects Am J Kidney Dis 30 1997 659 664 (Pubitemid 27465360)
26. J.L. Tycho Vuurmans, W.H. Boer, and W.J. Bos Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients J Am Soc Nephrol 13 2002 177 183 (Pubitemid 34042025)
27. J.K. Inrig Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis Am J Kidney Dis 55 2010 580 589
28. A.A. Lopes, J.L. Bragg-Gresham, and S.P.B. Ramirez Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS Nephrol Dial Transplant 24 2009 2809 2816
29. G. Cice, A. Di Benedetto, and S. D'Isa Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: a double-blind, placebo-controlled trial J Am Coll Cardiol 56 2010 1701 1708
30. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920 (Pubitemid 37323253)